Skip to main content
SpringerLink
Log in

Pharmacological Treatment of Acute Migraine in Adolescents and Children

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Migraine is a common disease in children and adolescents. The incidence of migraine has increased alarmingly in the general population during recent decades. Migraine causes considerable individual suffering and impaired quality of life. Therefore, appropriate management is essential. In this article, the treatment of acute migraine in children and adolescents will be reviewed. Only a few randomized controlled studies have been published and high placebo rates are a major problem for proving superiority of active drugs. Generally, acetaminophen (paracetamol) and ibuprofen are accepted as drugs of first choice, even though the evidence is poor for the former and limited for latter. Among 14 studies on triptans in adolescents, 9 showed some superiority over placebo with respect to pain relief and pain freedom, and among 6 studies in children, 5 suggest some superiority over placebo. Sumatriptan nasal spray and zolmitriptan nasal spray have been approved for adolescents in Europe; almotriptan has been approved for adolescents in the USA, as has rizatriptan for patients aged 6–17 years. A recent study demonstrated the efficacy of a fixed combination of sumatriptan and naproxen in adolescents with migraine. In conclusion, evidence for the pharmacological treatment of acute migraine in children is very poor and evidence for adolescents is better but still limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Özge A, Termine C, Antonaci F, et al. Overview of diagnosis and management of paediatric headache. Part I: diagnosis. J Headache Pain. 2011;12(1):13–23.

    Article  PubMed  Google Scholar 

  2. Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088–97.

    Article  PubMed  Google Scholar 

  3. Anttila P, Metsähonkala L, Sillanpää M. Long-term trends in the incidence of headache in Finnish schoolchildren. Pediatrics. 2006;117(6):e1197–201.

    Article  PubMed  Google Scholar 

  4. Wöber-Bingöl Ç, Wöber C, Karwautz A, et al. Diagnosis of headache in childhood and adolescence: a study in 437 patients. Cephalalgia. 1995;15(1):13–21.

    Article  PubMed  Google Scholar 

  5. Wöber-Bingöl Ç, Wöber C, Karwautz A, et al. Clinical features of migraine: a cross-sectional study in patients aged three to sixty-nine. Cephalalgia. 2004;24(1):12–7.

    Article  PubMed  Google Scholar 

  6. Wöber-Bingöl Ç, Martin IP. Managing headache in young people. In: Martelletti P, Steiner TJ, editors. Handbook of headache. Practical management. Berlin: Springer; 2011. p. 565–78.

    Chapter  Google Scholar 

  7. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia. 2004;24(Suppl 1):1–160.

    Google Scholar 

  8. Kienbacher C, Wöber C, Zesch H, et al. Clinical features, classification and prognosis of migraine and tension-type headache in children and adolescents: a long-term follow-up study. Cephalalgia. 2006;26(7):820–30.

    Article  PubMed  CAS  Google Scholar 

  9. Arruda MA, Bigal ME. Migraine and migraine subtypes in preadolescent children: association with school performance. Neurology. 2012;79(18):1881–8.

    Article  PubMed  Google Scholar 

  10. Arruda MA, Bigal ME. Behavioral and emotional symptoms and primary headaches in children: a population-based study. Cephalalgia. 2012;32(15):1093–100.

    Article  PubMed  Google Scholar 

  11. Kröner-Herwig B, Gassmann J. Headache disorders in children and adolescents: their association with psychological, behavioral, and socio-environmental factors. Headache. 2012;52(9):1387–401.

    Article  PubMed  Google Scholar 

  12. Karwautz A, Wöber C, Lang T, Böck A, Wagner-Ennsgraber C, Vesely C, et al. Psychosocial factors in children and adolescents with migraine and tension-type headache: a controlled study and review of the literature. Cephalalgia. 1999;19(1):32–43.

    Article  PubMed  CAS  Google Scholar 

  13. Kernick D, Reinhold D, Campbell JL. Impact of headache on young people in a school population. Br J Gen Pract. 2009;59(566):678–81.

    Article  PubMed  Google Scholar 

  14. Wöber-Bingöl Ç, Hershey A. Migraine co-morbidities in children. In: Schoenen J, Sandor P, Dodick D, editors. Co-morbidity in migraine—clinical aspects, prevalence, mechanisms and management. Chichester: Wiley-Blackwell; 2011. p. 122–32.

    Google Scholar 

  15. Termine C, Özge A, Antonaci F, et al. Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J Headache Pain. 2011;12(1):25–34.

    Article  PubMed  Google Scholar 

  16. Abu-Arafeh I, Pearlman E. Childhood migraine and related syndromes. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The headaches. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 1073–7.

    Google Scholar 

  17. Evers S, Marziniak M, Frese A, et al. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies. Cephalalgia. 2009;29(4):436–44.

    Article  PubMed  CAS  Google Scholar 

  18. Benedetti F, Mayberg HS, Wager TD, et al. Neurobiological mechanisms of the placebo effect. J Neurosci. 2005;25(45):10390–402.

    Article  PubMed  CAS  Google Scholar 

  19. Hämäläinen ML, Hoppu K, Valkeila E, et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48(1):102–7.

    Article  Google Scholar 

  20. Lewis DW, Kellstein D, Dahl G, et al. Children’s ibuprofen suspension for the acute treatment of pediatric migraine headache. Headache. 2002;42(8):780–6.

    Article  PubMed  Google Scholar 

  21. Evers S, Rahmann A, Kraemer C, et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006;67(3):497–9.

    Article  PubMed  CAS  Google Scholar 

  22. Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin. 2009;25(9):2207–22.

    Article  PubMed  CAS  Google Scholar 

  23. Bárzaga Arencibia Z, Choonara I. Balancing the risks and benefits of the use of over-the-counter pain medications in children. Drug Saf. 2012;35(12):1119–25.

    Article  PubMed  Google Scholar 

  24. Hämäläinen ML, Hoppu K, Santavuori P. Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatr Neurol. 1997;16(2):114–7.

    Article  PubMed  Google Scholar 

  25. Hämäläinen M, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently than adults? Neurology. 1997;48(4):1100–3.

    Article  PubMed  Google Scholar 

  26. Uebarall MA. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999;52(7):1507–10.

    Article  Google Scholar 

  27. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106(5):989–97.

    Article  PubMed  CAS  Google Scholar 

  28. Winner P, Rothner AD, Wooten JD, et al. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache. 2006;46(2):212–22.

    Article  PubMed  Google Scholar 

  29. Ahonen K, Hämäläinen ML, Rantala H, et al. Nasal sumatriptan is effective in the treatment of migraine attacks in children. Neurology. 2004;62(6):883–7.

    Article  PubMed  CAS  Google Scholar 

  30. Wöber C, Wöber-Bingöl Ç. Intranasal sumatriptan for the acute treatment of migraine in children. (Letter). Neurology. 2000;54(5):1209–10.

    Article  PubMed  Google Scholar 

  31. Christensen ML, Mottern RK, Jabbour JT, et al. Pharmacokinetics of sumatriptan nasal spray in children. J Clin Pharmacol. 2004;44(4):359–67.

    Article  PubMed  CAS  Google Scholar 

  32. Christensen ML, Mottern RK, Jabbour JT, et al. Pharmacokinetics of sumatriptan nasal spray in adolescents. J Clin Pharmacol. 2003;43(7):721–6.

    PubMed  CAS  Google Scholar 

  33. Tfelt-Hansen P, Olesen J. Taking the negative view of current migraine treatments: the unmet needs. CNS Drugs. 2012;26(5):375–82.

    Article  PubMed  CAS  Google Scholar 

  34. Rothner AD, Wasiewski W, Winner P, et al. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache. 2006;46(1):101–9.

    Article  PubMed  Google Scholar 

  35. Lewis DW, Winner P, Hershey AD, et al. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007;120(2):390–6.

    Article  PubMed  Google Scholar 

  36. Dixon R, Engleman K, Kemp J, et al. A comparison of the pharmacokinetics and tolerability of the novel antimigraine compound zolmitriptan in adolescents and adults. J Child Adolesc Psychopharmacol. 1999;9(1):35–42.

    Article  PubMed  CAS  Google Scholar 

  37. Winner P, Lewis D, Visser WH, et al. Rizatriptan Adolescent Study Group. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache. 2002;42(1):49–55.

    Article  PubMed  Google Scholar 

  38. Visser WH, Winner P, Strohmaier K, Rizatriptan Protocol 059 and 061 Study Groups, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache. 2004;44(9):891–9.

    Article  PubMed  Google Scholar 

  39. Ahonen K, Hämäläinen ML, Eerola M, et al. A randomized trial of rizatriptan in migraine attacks in children. Neurology. 2006;67(7):1135–40.

    Article  PubMed  CAS  Google Scholar 

  40. Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 2012;32(10):750–65.

    Article  PubMed  Google Scholar 

  41. Hewitt DJ, Pearlman E, Hämäläinen M, et al. Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs. Headache. 2013;53(1):104–17.

    Article  PubMed  Google Scholar 

  42. Fraser IP, Han L, Han TH, et al. Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study. Headache. 2012;52(4):625–35.

    Article  PubMed  Google Scholar 

  43. Linder SL, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache. 2008;48(9):1326–36.

    Article  PubMed  Google Scholar 

  44. Berenson F, Vasconcellos E, Pakalnis A, et al. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents. Headache. 2010;50(5):795–807.

    Article  PubMed  Google Scholar 

  45. Baldwin JR, Fleishaker JC, Azie NE, et al. A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults. Cephalalgia. 2004;24(4):288–92.

    Article  PubMed  CAS  Google Scholar 

  46. Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Headache. 2007;47(4):511–8.

    Article  PubMed  Google Scholar 

  47. Khoury CK, Couch JR. Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal. Drug Des Devel Ther. 2010;4:9–17.

    Article  PubMed  CAS  Google Scholar 

  48. Derosier FJ, Lewis D, Hershey AD, Winner PK, Pearlman E, Rothner AD, Linder SL, Goodman DK, Jimenez TB, Granberry WK, Runken MC. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics. 2012;129(6):e1411–20.

    Article  PubMed  Google Scholar 

  49. McDonald SA, Hershey AD, Pearlman E, et al. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents. Headache. 2011;51(9):1374–87.

    Article  PubMed  Google Scholar 

  50. Walls CM, Berges AC, Dalton ZX, et al. Pharmacokinetics of sumatriptan and naproxen following the administration of a single combination tablet at three doses to adolescent subjects with migraine and healthy adult subjects. Headache. 2010;50(S1):8–9.

    Google Scholar 

  51. Lindkvist J, Airaksinen M, Kaukonen AM, et al. Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994–2007. Br J Clin Pharmacol. 2011;71(6):929–35.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

No funding was provided for the preparation of this paper. The author has no conflicts of interest to declare. No other persons have made contributions to this work.

Author information

Authors and Affiliations

  1. Department of Child and Adolescent Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria

    Çiçek Wöber-Bingöl

Authors
  1. Çiçek Wöber-Bingöl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Çiçek Wöber-Bingöl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wöber-Bingöl, Ç. Pharmacological Treatment of Acute Migraine in Adolescents and Children. Pediatr Drugs 15, 235–246 (2013). https://doi.org/10.1007/s40272-013-0019-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40272-013-0019-3

Keywords

Search

Navigation